Ren and colleagues have discovered a role of the CBL/JAK2/RAB27B/ZDHHC9 signaling axis in regulating NRAS trafficking to the plasma membrane for activation by palmitoylation in myeloid malignancies (14) (Figure 1). Here, NRAS is linked to myeloid neoplasm.